https://mk-5108inhibitor.com/a....-new-spectral-cluste
This study compared the lasting outcomes of D2 and D1+ LND for AGC. TECHNIQUES We retrospectively evaluated data on 1121 customers which underwent curative distal gastrectomy and had pathologic stage of ≥ pT2 or pN+. The clients had been categorized into the D1+ and D2 LND groups, and long-lasting survival had been compared into the original and propensity score matching (PSM) cohorts. OUTCOMES Overall, 909 and 212 patients underwent D2 and D1+ LND, respectively. The D2 t
Like
Comment
Share
